# Pharmacokinetics and Pharmacodynamics of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Phase 2 Trials for Dose Selection in the Pivotal Phase 3 Trial

> Research article (The Journal of Clinical Pharmacology, 2017) · cited 38× · AI/ML

**Wikidata**: [openalex:W2590005725](https://www.wikidata.org/wiki/openalex:W2590005725)  
**Source**: https://4ort.xyz/entity/pharmacokinetics-and-pharmacodynamics-of-tolvaptan-in-autosomal-dominant-polycystic-kidney-disease-phase-2-trials-for-do
